Alpine Immune Sciences Long Term Debt

Alpine Immune Sciences (ALPN) currently reports a long-term debt of $8.7M as of March 2024. That compares with $9.8M in the prior-year period — down 11.5% year over year. Use the charts on this page to explore Alpine Immune Sciences's long-term debt history and peer comparisons.

Alpine Immune Sciences's long-term debt decreased from $9.8M to $8.7M — a 11.5% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alpine Immune Sciences reported $8.7M in long-term debt as of March 2024. That compares with $9.8M in the prior-year period — down 11.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $8.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alpine Immune Sciences, and consider following ALPN for alerts when major investors trade the stock.

Alpine Immune Sciences is classified in the Healthcare sector. On long-term debt, it currently shows $8.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALPN with unrelated industries.